Indiana University and Comprehensive Cancer Center — Indianapolis, Indiana

Indiana University and Comprehensive Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University and Comprehensive Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL).

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University and Comprehensive Cancer Center?

Indiana University and Comprehensive Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University and Comprehensive Cancer Center conducted?

Indiana University and Comprehensive Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL).

Is Indiana University and Comprehensive Cancer Center accredited by Crixeo Health?

Indiana University and Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University and Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.